Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/9824
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCollier, Sigrid-
dc.contributor.authorGrant, Merridy-
dc.contributor.authorSemeere, Aggrey-
dc.contributor.authorByakwaga, Helen-
dc.contributor.authorLaker-Oketta, Miriam-
dc.contributor.authorChemtai, Linda-
dc.contributor.authorLagat, Celestine-
dc.contributor.authorPhan, Jolie-
dc.contributor.authorNg, Kevin-
dc.contributor.authorD Wagner, Anjuli-
dc.contributor.authorV Basse, Ingrid-
dc.contributor.authorMaurer, Toby-
dc.contributor.authorMartin, Jeffrey-
dc.contributor.authorKiprono, Samson-
dc.contributor.authorE Freeman, Esther-
dc.date.accessioned2025-07-17T06:37:28Z-
dc.date.available2025-07-17T06:37:28Z-
dc.date.issued2025-04-22-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/9824-
dc.description.abstractKaposi’s sarcoma (KS) remains common in sub-Saharan Africa and despite persistently high mortality less than 50% of people with advanced-stage KS with an indica>on for chemotherapy currently receive it in western Kenya. To address this, a tailored mul>-component naviga>on strategy including physical naviga>on and care coordina>on, peer mentorship, educa>on, assistance with health insurance, a health insurance s>pend, and transporta>on s>pends was implemented within AMPATH healthcare network in western Kenya in 2021. This study evaluates service penetra>on (engagement), acceptability, appropriateness, and fidelity to the mul>-component naviga>on strategy. We used a convergent mixed methods approach using Proctor et al.’s framework for implementa>on outcomes. We enrolled all adults with newly diagnosed HIV-associated KS from 2021 to 2024. Quan>ta>ve data included structured ques>onnaires, CD4+ T cell count, and naviga>on ac>vity logs. Scores for acceptability and appropriateness ques>onnaires ranged from 4 to 20, with 20 represen>ng high levels. In-depth interviews were also conducted among people with HIV-associated KS, healthcare workers, and naviga>on team members. Descrip>ve sta>s>cs were used for measures of service penetra>on (engagement), acceptability, appropriateness, and fidelity. Framework analysis was used for in-depth interviews. Among the 124 Adults with HIV associated KS eligible to par>cipate, service penetra>on was 74% within 90 days aher KS diagnosis. The median acceptability score among people with HIV- associated KS was 20 (Range: 19, 20) and appropriateness was 20 (Range 20, 20). Fidelity to at least one component was 87% (N=80), and no par>cipant experienced all 6 components.Fidelity was 2.2% (N=2) for the transporta>on s>pends (7 total) and 28% (N=26) for the health insurance enrollment s>pend. During in-depth interviews, pa>ents and healthcare workers described high levels of acceptability and appropriateness of the naviga>on strategy. Pa>ents described experiences of variability in naviga>on strategy components, and healthcare worker and naviga>on team members described how financial constraints and >me constraints contributed to variability in fidelity. A mul>-component naviga>on strategy designed to improve chemotherapy engagement for HIV-associated KS was both acceptable and appropriate. Fidelity was variable with low fidelity to financial components, sugges>ng areas for future adapta>on to ensure sustainability and context appropriateness during integra>on into the health system and future scale-up.en_US
dc.language.isoenen_US
dc.publishermedRxiven_US
dc.subjectKaposi’s Sarcomaen_US
dc.subjectHIVen_US
dc.subjectmul>-component strategyen_US
dc.titleService penetra>on, acceptability, appropriateness, and fidelity of a mul>component naviga>on strategy for HIV-associated Kaposi’s Sarcoma: mixed methods evalua>onen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
KIPRONO.pdf286.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.